Europe Nasal Delivery Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country

TIPRE00018195 | Pages: 134 | Medical Device | Jan 2021 | Type: Regional | Status: Published

Market Introduction

Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Nasal drug delivery is one of the efficient routes of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.

 


Get more information on this report :



Market Overview and Dynamics

The Europe nasal delivery devices market is expected to reach US$ 24,072.24 million in 2027 from US$ 15,140.36 million in 2019. The market is estimated to grow with a CAGR of 6.0% from 2020-2027. The growth of the market is attributed to some key driving factors such as the rising geriatric population and government initiatives and the increasing incidences of neurological disorders. However, the market growth is likely to be hindered owing to the concerns associated with nasal drug delivery market.

 

Key Market Segments

Based on drug type, the nasal delivery devices market is anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. Based on delivery technologies, the nasal delivery devices market, is segmented into spray, nebulizers, inhalers, and others. Based on end user, the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources for nasal delivery devices market included in the report are Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG), Scientific World Journal, and others.

Reasons to buy the report

  • To understand the Europe nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
  • Efficiently plan M&A and partnership deals in Europe nasal delivery devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region

 

EUROPE NASAL DELIVERY DEVICES MARKET SEGMENTATION

 

By Drug Type

  • Anaesthetics
  • Antibiotics
  • Pain Relief Drugs
  • Calcium Supplements
  • Vasoconstrictors
  • Antihistamines
  • Others

 

By Delivery Technologies

  • Spray
  • Nebulizers
  • Inhalers
  • Others

 

By End User

  • Home Care Settings
  • Hospitals
  • Clinics

 

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

 

Company Profiles

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddy's Laboratories
 

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Nasal Delivery Devices Market – By Drug Type

1.3.2        Nasal Delivery Devices Market – By Delivery Technologies

1.3.3        Nasal Delivery Devices Market – By End User

1.3.4        Europe Nasal Delivery Devices Market – By Country

2.          Europe Nasal Delivery Devices Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe Nasal Delivery Devices Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Nasal Delivery Devices Market- Europe PEST Analysis

4.3        Expert Opinion

5.          Europe Nasal Delivery Devices Market - Key Market Dynamics

5.1        Market Drivers

5.1.1        RisingGeriatric Population and Government Initiatives

5.1.2        Increasing Incidences of Neurological Disorders

5.2        Market Restraints

5.2.1        ConcernsAssociated with Nasal Drug Delivery Market

5.3        Market Opportunities

5.3.1        Increasing Awareness Among Patients

5.4        Future Trends

5.4.1        Increasing Advancements in Technologies Regarding Nasal Drug Delivery Devices

5.5        Impact Analysis

6.          Nasal Delivery Devices Market – Europe Analysis

6.1        Europe Nasal Delivery Devices Market Revenue Forecasts and Analysis

7.          Europe Nasal Delivery Devices Market Analysis and Forecasts To 2027 – By Drug Type

7.1        Overview

7.2        Nasal Delivery Devices Market Revenue Share, by Drug Type(2019 and 2027)

7.3        Anaesthetics

7.3.1        Overview

7.3.2        Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.4        Antibiotics

7.4.1        Overview

7.4.2        Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.5        Pain Relief Drugs

7.5.1        Overview

7.5.2        Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.6        Calcium Supplements

7.6.1        Overview

7.6.2        Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.7        Vasoconstrictors

7.7.1        Overview

7.7.2        Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.8        Antihistamines

7.8.1        Overview

7.8.2        Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

7.9        Others

7.9.1        Overview

7.9.2        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.          Europe Nasal Delivery Devices Market Analysis – By Delivery Technologies

8.1        Overview

8.2        Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)

8.3        Spray

8.3.1        Overview

8.3.2        Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.4        Nebulizers

8.4.1        Overview

8.4.2        Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.5        Inhalers

8.5.1        Overview

8.5.2        Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

8.6        Others

8.6.1        Overview

8.6.2        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.          Europe Nasal Delivery Devices Market Analysis – By End-User

9.1        Overview

9.2        Nasal Delivery Devices Market Revenue Share, by End -User(2019 and 2027)

9.3        Home Care Settings

9.3.1        Overview

9.3.2        Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.4        Hospitals

9.4.1        Overview

9.4.2        Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

9.5        Clinics

9.5.1        Overview

9.5.2        Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

10.       Nasal Delivery Devices Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      Europe: Nasal Delivery Devices Market

10.1.1     Overview

10.1.2     Europe: Nasal Delivery Devices Market - Revenue and Forecast to 2027 (USD Million)

10.1.3     Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.4     Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027  (USD Million)

10.1.5     Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6     Europe: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)

10.1.7     Germany: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Germany: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Germany Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Germany Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Germany Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8     UK: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       UK: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       UK Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       UK Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       UK Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9     France: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       France: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       France Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       France Nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)

10.1.9.4       France Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.10   Spain: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    Spain: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    Spain Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

10.1.10.3    Spain Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    Spain Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.11   Italy: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Italy: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Italy Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Italy Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Italy Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.12   Rest of Europe: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.12.1    Rest of Europe: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

10.1.12.2    Rest of Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

10.1.12.3    Rest of Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

10.1.12.4    Rest of Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Europe Nasal Delivery Devices Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.       COMPANY PROFILES

12.1      GlaxoSmithKline plc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      AstraZeneca

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Pfizer Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

13.       Appendix

13.1      About the Insight Partners

13.2      Glossary of terms

LIST OF TABLES

Table 1.            Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

Table 3.            Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 4.            Germany Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 5.            Germany Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027  (USD Million)

Table 6.            Germany Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.            UK Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 8.            UK Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 9.            UK Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 10.          France Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 11.          France Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)

Table 12.          France Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

Table 15.          Spain Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Italy Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

Table 18.          Italy Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          Rest of Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          Rest of Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 22.          Glossary of Terms, Nasal Delivery Devices Market

LIST OF FIGURES

Figure 1.           Nasal Delivery DevicesMarket Segmentation

Figure 2.           Europe Nasal Delivery Devices Market Overview

Figure 3.           Antihistamines Segment Held Largest Share of Drug Type in Nasal Delivery DevicesMarket

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Nasal Delivery Devices Market - Europe PEST Analysis

Figure 6.           Nasal Delivery Devices Market Impact Analysis of Driver and Restraints

Figure 7.           Europe Nasal Delivery Devices Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)

Figure 9.           Anaesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)

Figure 17.        Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)

Figure 22.        Home Care Settings: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Hospitals: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Europe: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)

Figure 26.        Europe Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)

Figure 27.        Europe: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)

Figure 28.        Germany: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        UK: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        France: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Spain: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Italy: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Rest of Europe: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        Impact of COVID-19 Pandemic in Europe Country Markets

 

 

  1. GlaxoSmithKline plc.
  2. AstraZeneca
  3. Pfizer Inc.
  4. BD
  5. Sanofi
  6. Merck & Co., Inc.
  7. Cadila Pharmaceuticals Ltd.
  8. Novartis AG
  9. Dr. Reddy's Laboratories
  • To understand the Europe nasal delivery devices market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for nasal delivery devices market
  • Efficiently plan M&A and partnership deals in Europe nasal delivery devices market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Nasal delivery devices market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Europe region
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000